- Speakers: Julia Fox-Rushby and Rositsa Koleva-Kolarova
- Time: 10am-5pm
- Booking: Postponed
- Contact: email BRCtraining@gstt.nhs.uk or call 020 7188 7188 ext 51239 or 53373
Who is the course for?
This overview is aimed at people who are interested in learning about the basics of applying economic evaluation to healthcare interventions. The course should enable people from a wide variety of professions and disciplines who are:
- considering adding health economics to a clinical trial, quasi-experimental or observational study of surgical, medical or public health interventions;
- working on projects which involve economic evaluations;
- reading journal papers presenting economic evaluations of interventions in their specialist area;
…and who want to understand a little more about the purpose, aims, and methods of applying economic evaluation to evaluating healthcare interventions.
This overview introduces the reason for undertaking economic evaluation and outlines how different types of economic evaluation support decision-making. It shows how costs and outcomes, including quality adjusted life years (QALYs), might be measured, compared, presented and traded-off.
- Understand the rationale and role of economic evaluation as a tool for resource allocation and priority setting
- Identify different types of economic evaluations and how these vary by outcomes measured and potential decision-making
- Understand the principles of moving from measuring health status to calculating QALYs
- Understand the range of costs that could be measured
- Presenting results of economic evaluations.
About the trainers
Julia Fox-Rushby is Professor of Health Economics in the Department of Population Health and Environmental Sciences at King’s College London. She also leads health economics for the Papworth Trials Unit Collaboration (a collaboration between Papworth Hospital, Kings College London and Cambridge University).
Rositsa Koleva-Kolarova is a post-doctoral research fellow in the Department of Population Health and Environmental Sciences at King’s College London. She has published cost-effectiveness models on breast cancer screening and follow-up, and is currently reviewing the application of economic evaluation.